or Try an Advanced Search...

    Anilides Stocks List

    Symbol Grade Name % Change
    VRTX C Vertex Pharmaceuticals Incorporated 0.04
    NTRB D Nutriband Inc. -0.30
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Analgesics Autoimmune Disease Breakthrough Therapy Chemical Compounds Chronic Pain Cyclopropanes Cystic Fibrosis Euphoriants Fentanyl Genotype HCV HCV Infection Hepatitis C Hepatitis C Virus Heroin Infection Influenza Morphine Nasdaq 100 Opioids

    Related ETFs - A few ETFs which own one or more of the above listed Anilides stocks.

    Symbol Grade Name Weight
    BBH C Market Vectors Biotech ETF 9.32
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.07
    IBB C iShares Nasdaq Biotechnology Index Fund 8.06
    BIS D ProShares UltraShort Nasdaq Biotechnology 7.21
    BIB C ProShares Ultra Nasdaq Biotechnology 5.75
    View all Anilides ETFs...
    Compare ETFs
    Compare BBH to BIS Compare BBH to IBBQ Compare IBB to BIS

        Anilides Stocks Recent News

        Date Stock Title
        May 9 VRTX Bluebird bio spikes even as CRISPR leads in gene therapy rollout
        May 9 VRTX CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
        May 9 VRTX Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
        May 9 VRTX Dow Jones Futures: S&P 500 Holds, Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers Late
        May 8 VRTX A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
        May 8 VRTX Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
        May 8 VRTX Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
        May 8 VRTX Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
        May 8 VRTX 5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
        May 7 VRTX Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
        May 7 VRTX Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
        May 7 VRTX Vertex Pharmaceuticals Inc (VRTX) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...
        May 7 VRTX Vertex Pharmaceuticals, Inc. (VRTX) Q1 2024 Earnings Call Transcript
        May 7 VRTX Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
        May 6 VRTX UPDATE 1-Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
        May 6 VRTX Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
        May 6 VRTX Vertex provides another EPS beat as net income rises 56% in Q1
        May 6 VRTX Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
        May 6 VRTX Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key
        May 6 VRTX Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
        Related Industries: Biotechnology
        Related Stock Lists: Analgesics Autoimmune Disease Breakthrough Therapy Chemical Compounds Chronic Pain Cyclopropanes Cystic Fibrosis Euphoriants Fentanyl Genotype HCV HCV Infection Hepatitis C Hepatitis C Virus Heroin Infection Influenza Morphine Nasdaq 100 Opioids
        Anilides

        In organic chemistry, anilides (or phenylamides) are a class of organic compounds with the general structure R−C(=O)−N(−R’)−C6H5. They are amide derivatives of aniline (H2N−C6H5).

        More about Anilides
        Browse All Tags